AcelRx Pharmaceuticals, Inc.
|Number of Estimates|
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
Market Cap: 149 Million
Primary Exchange: NASDAQ
Shares Outstanding: 79.6 Million
Float: 70.5 Million
Sector: Health Technology
Industry: Pharmaceuticals: Other
Longest drawdown: 1654 trading days
From: 2013-07-22 To: 2019-12-06
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|